Related references
Note: Only part of the references are listed.Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients
Guido Gembillo et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2022)
Esaxerenone, a novel nonsteroidal mineralocorticoid receptor blocker (MRB) in hypertension and chronic kidney disease
Ningning Wan et al.
JOURNAL OF HUMAN HYPERTENSION (2021)
Country-Specific Prevalence and Incidence of Youth-Onset Type 2 Diabetes: A Narrative Literature Review
Jane L. Lynch et al.
ANNALS OF NUTRITION AND METABOLISM (2021)
Early-onset of type 2 diabetes mellitus is a risk factor for diabetic nephropathy progression: a biopsy-based study
Yucheng Wu et al.
Aging-US (2021)
Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia
Guido Gembillo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease
Ferdinando Carlo Sasso et al.
CARDIOVASCULAR DIABETOLOGY (2021)
Kidney Biopsy in Type 2 Diabetic Patients: Critical Reflections on Present Indications and Diagnostic Alternatives
Domenico Santoro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical Factors
Annalisa Giandalia et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Vitamin D and Glomerulonephritis
Guido Gembillo et al.
MEDICINA-LITHUANIA (2021)
Microvascular Complications of Type 2 Diabetes Mellitus
Charles Faselis et al.
CURRENT VASCULAR PHARMACOLOGY (2020)
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino et al.
EUROPEAN HEART JOURNAL (2020)
Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function
Giuseppe Pugliese et al.
JOURNAL OF NEPHROLOGY (2020)
The NADPH Oxidase Family and Its Inhibitors
Mathieu Chocry et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
Adolescent Obesity and Early-Onset Type 2 Diabetes
Gilad Twig et al.
DIABETES CARE (2020)
Inflammasome activation in podocytes: a new mechanism of glomerular diseases
Wei Xiong et al.
INFLAMMATION RESEARCH (2020)
Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy
Sandra Rayego-Mateos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Type 1 diabetes—origins and epidemiology
Suvi M Virtanen et al.
Lancet Diabetes & Endocrinology (2020)
Production of Sorbitol via Catalytic Transfer Hydrogenation of Glucose
Beatriz Garcia et al.
APPLIED SCIENCES-BASEL (2020)
Acute Coronary Syndromes in Chronic Kidney Disease: Clinical and Therapeutic Characteristics
Madalina Ioana Moisi et al.
MEDICINA-LITHUANIA (2020)
Glomerular Filtration Rate as a Predictor of Outcome in Acute Coronary Syndrome Complicated by Atrial Fibrillation
Domenico Santoro et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Young-onset type 2 diabetes mellitus - implications for morbidity and mortality
Dianna J. Magliano et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
Protective Role of Vitamin D in Renal Tubulopathies
Guido Gembillo et al.
METABOLITES (2020)
Current Data Regarding the Relationship between Type 2 Diabetes Mellitus and Cardiovascular Risk Factors
Cosmin Mihai Vesa et al.
DIAGNOSTICS (2020)
Renal Effects of Sulodexide in Type 2 Diabetic Patients without Nephrotic Range Proteinuria
Kachonsak Yongwatana et al.
JOURNAL OF DIABETES RESEARCH (2020)
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial
David Z I Cherney et al.
Lancet Diabetes & Endocrinology (2020)
Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update
Stefanos Roumeliotis et al.
JOURNAL OF CLINICAL MEDICINE (2020)
The genetic map of diabetic nephropathy: evidence from a systematic review and meta-analysis of genetic association studies
Maria Tziastoudi et al.
CLINICAL KIDNEY JOURNAL (2020)
Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury
Jun Su et al.
MOLECULAR BIOLOGY REPORTS (2020)
APX-115, a pan-NADPH oxidase inhibitor, protects development of diabetic nephropathy in podocyte specific NOX5 transgenic mice
Eun Soo Lee et al.
FREE RADICAL BIOLOGY AND MEDICINE (2020)
Advanced Glycation End Product Inhibitor Pyridoxamine Attenuates IVD Degeneration in Type 2 Diabetic Rats
Juliane D. Glaeser et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Oxidative stress in chronic kidney disease
Kristien Daenen et al.
PEDIATRIC NEPHROLOGY (2019)
Pioglitazone: The forgotten, cost-effective cardioprotective drug for type 2 diabetes
Ralph A. DeFronzo et al.
DIABETES & VASCULAR DISEASE RESEARCH (2019)
Epigenetics and epigenomics in diabetic kidney disease and metabolic memory
Mitsuo Kato et al.
NATURE REVIEWS NEPHROLOGY (2019)
Adipokine Dysregulation and Insulin Resistance with Atherosclerotic Vascular Disease: Metabolic Syndrome or Independent Sequelae?
Mohan Satish et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2019)
Exercise and insulin resistance in type 2 diabetes mellitus: A systematic review and meta-analysis
A. Sampath Kumar et al.
ANNALS OF PHYSICAL AND REHABILITATION MEDICINE (2019)
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Hiddo J. L. Heerspink et al.
LANCET (2019)
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein et al.
LANCET (2019)
Role of Vitamin D Status in Diabetic Patients with Renal Disease
Guido Gembillo et al.
MEDICINA-LITHUANIA (2019)
Association of Higher Advanced Oxidation Protein Products (AOPPs) Levels in Patients with Diabetic and Hypertensive Nephropathy
Giovanni Conti et al.
MEDICINA-LITHUANIA (2019)
Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
Interleukin-18 and diabetic nephropathy: A review
Habib Yaribeygi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
RAAS inhibitors directly reduce diabetes-induced renal fibrosis via growth factor inhibition
Sandor Koszegi et al.
JOURNAL OF PHYSIOLOGY-LONDON (2019)
The classic signalling and trans-signalling of interleukin-6 are both injurious in podocyte under high glucose exposure
Chun-Tao Lei et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism
Wusheng Xiao et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Type 2 Diabetes in Children and Adolescents
Constadina Panagiotopoulos et al.
CANADIAN JOURNAL OF DIABETES (2018)
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
Steven J. Forrester et al.
CIRCULATION RESEARCH (2018)
Diabetic Kidney Disease: A Determinant of Cardiovascular Risk in Type 1 Diabetes
Ian H. de Boer et al.
DIABETES CARE (2018)
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
N. H. Cho et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2018)
Renal protection by sodium-glucose cotransporter 2 inhibitors and its underlying mechanisms in diabetic kidney disease
Akira Mima
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2018)
Update of pathophysiology and management of diabetic kidney disease
Yi-Chih Lin et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2018)
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
Katherine R. Tuttle et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies
Roberto Minutolo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Intervention using vitamin D for elevated urinary albumin in type 2 diabetes mellitus (IDEAL-2 Study): study protocol for a randomised controlled trial
Shahrad Taheri et al.
TRIALS (2018)
The kidney and cardiovascular outcome trials
Zachary Bloomgarden
JOURNAL OF DIABETES (2018)
Type 2 diabetes in adolescents and young adults
Nadia Lascar et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
DNA methylation in the pathogenesis of type 2 diabetes in humans
Cajsa Davegardh et al.
MOLECULAR METABOLISM (2018)
Emerging Role of Adipocytokines in Type 2 Diabetes as Mediators of Insulin Resistance and Cardiovascular Disease
Ravindran Jaganathan et al.
CANADIAN JOURNAL OF DIABETES (2018)
Epigenetics and Epigenomics: Implications for Diabetes and Obesity
Evan D. Rosen et al.
DIABETES (2018)
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis
Rossella Siligato et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2018)
Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk
Dario Giugliano et al.
ENDOCRINE (2018)
The Genetic Landscape of Renal Complications in Type 1 Diabetes
Niina Sandholm et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Adiponectin and Its Receptors in Diabetic Kidney Disease: Molecular Mechanisms and Clinical Potential
Dongqing Zha et al.
ENDOCRINOLOGY (2017)
Novel avenues for treating diabetic nephropathy: new investigational drugs
Viviana Lacava et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Endothelin ETA Receptor Blockade, by Activating ETB Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid Retentions
Magali Vercauteren et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Insights into Diabetic Kidney Disease Using Urinary Proteomics and Bioinformatics
Julie A. D. Van et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Cardiovascular events and death in Japanese patients with chronic kidney disease
Kenichi Tanaka et al.
KIDNEY INTERNATIONAL (2017)
APX-115, a first-in-class pan-NADPH oxidase (Nox) inhibitor, protects db/db mice from renal injury
Jin Joo Cha et al.
LABORATORY INVESTIGATION (2017)
Molecular mechanisms involved in podocyte EMT and concomitant diabetic kidney diseases: an update
Qidi Ying et al.
RENAL FAILURE (2017)
Sulodexide Protects Renal Tubular Epithelial Cells from Oxidative Stress-Induced Injury via Upregulating Klotho Expression at an Early Stage of Diabetic Kidney Disease
Yu Ning Liu et al.
JOURNAL OF DIABETES RESEARCH (2017)
NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes
Sachin V. Suryavanshi et al.
FRONTIERS IN PHARMACOLOGY (2017)
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial
Kohjiro Ueki et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Renin-angiotensin-aldosterone (RAAS): The ubiquitous system for homeostasis and pathologies
Seema Patel et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Endothelin A receptor antagonists in diabetic kidney disease
Panagiotis I. Georgianos et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2017)
Neutrophil gelatinase associated lipocalin (NGAL) is elevated in type 2 diabetics with carotid artery stenosis and reduced under metformin treatment
W. Eilenberg et al.
CARDIOVASCULAR DIABETOLOGY (2017)
Social Determinants of Health and Racial/Ethnic Disparities in Type 2 Diabetes in Youth
Ashley M. Butler
CURRENT DIABETES REPORTS (2017)
Sodium-Glucose Co-transporters and Their Inhibition: Clinical Physiology
Ele Ferrannini
CELL METABOLISM (2017)
Incidence of chronic kidney disease among people with diabetes: a systematic review of observational studies
D. N. Koye et al.
DIABETIC MEDICINE (2017)
Genetic-Variation-Driven Gene-Expression Changes Highlight Genes with Important Functions for Kidney Disease
Yi-An Ko et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2017)
Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension Studies
Peter P. Toth et al.
CIRCULATION (2017)
Fasting insulin, insulin resistance and risk of hypertension in the general population: A meta-analysis
Feng Wang et al.
CLINICA CHIMICA ACTA (2017)
Proposed model for a Romanian register of chronic diseases in children
Florina Maria Gabor-Harosa et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2016)
Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies
Petter Bjornstad et al.
CURRENT DIABETES REPORTS (2016)
PCSK9 in diabetic kidney disease
Usama Elewa et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2016)
Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes
Salvatore De Cosmo et al.
JOURNAL OF HYPERTENSION (2016)
Management of patients with diabetes and CKD: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Vlado Perkovic et al.
KIDNEY INTERNATIONAL (2016)
Diabetes mellitus statistics on prevalence and mortality: facts and fallacies
Paul Zimmet et al.
NATURE REVIEWS ENDOCRINOLOGY (2016)
Pioglitazone after Ischemic Stroke or Transient Ischemic Attack
W. N. Kernan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies
James Yarmolinsky et al.
SCIENTIFIC REPORTS (2016)
Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes
Kanna Nagaishi et al.
SCIENTIFIC REPORTS (2016)
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Marja-Riitta Taskinen et al.
ATHEROSCLEROSIS (2015)
Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add-on therapy in subjects with new-onset diabetes. Results from the Efficacy and Durability of Initial Combination Therapy for Type 2 Diabetes (EDICT): a randomized trial
M. A. Abdul-Ghani et al.
DIABETES OBESITY & METABOLISM (2015)
Pathophysiology of diabetic dyslipidaemia: where are we?
Bruno Verges
DIABETOLOGIA (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Treatment with Sildenafil Improves Insulin Sensitivity in Prediabetes: A Randomized, Controlled Trial
Claudia E. Ramirez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Microvascular Complications and Foot Care
[Anonymous]
DIABETES CARE (2015)
Diabetic kidney disease in children and adolescents
Maryam Afkarian
PEDIATRIC NEPHROLOGY (2015)
Vitamin B and its derivatives for diabetic kidney disease
Amit D. Raval et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Clinical Challenges in Diagnosis and Management of Diabetic Kidney Disease
Robert C. Stanton
AMERICAN JOURNAL OF KIDNEY DISEASES (2014)
Kidney lesions in diabetic patients with normoalbuminuric renal insufficiency
Miho Shimizu et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2014)
Improved Survival and Renal Prognosis of Patients With Type 2 Diabetes and Nephropathy With Improved Control of Risk Factors
Gudbjorg Andresdottir et al.
DIABETES CARE (2014)
The SEARCH for Diabetes in Youth Study: Rationale, Findings, and Future Directions
Richard F. Hamman et al.
DIABETES CARE (2014)
Diabetic Kidney Disease: A Report From an ADA Consensus Conference
Katherine R. Tuttle et al.
DIABETES CARE (2014)
Microvascular dysfunction as a link between obesity, insulin resistance and hypertension
U. Karaca et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2014)
Protein kinase C in enhanced vascular tone in diabetes mellitus
Igor V. Kizub et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Understanding the Epigenetic Syntax for the Genetic Alphabet in the Kidney
Katalin Susztak
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Integrative Biology Identifies Shared Transcriptional Networks in CKD
Sebastian Martini et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The effect of RAAS blockade on the progression of diabetic nephropathy
Sara S. Roscioni et al.
NATURE REVIEWS NEPHROLOGY (2014)
Efficacy and Safety of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Mellitus Patients with Moderate to Severe Renal Impairment: A Systematic Review and Meta-Analysis
Dongsheng Cheng et al.
PLOS ONE (2014)
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Jonathan E. Campbell et al.
CELL METABOLISM (2013)
Long-Term Complications and Mortality in Young-Onset Diabetes
Maria I. Constantino et al.
DIABETES CARE (2013)
Lipid and Inflammatory Cardiovascular Risk Worsens Over 3 Years in Youth With Type 2 Diabetes The TODAY clinical trial
Ruth S. Weinstock et al.
DIABETES CARE (2013)
Renal Structure in Normoalbuminuric and Albuminuric Patients With Type 2 Diabetes and Impaired Renal Function
Elif I. Ekinci et al.
DIABETES CARE (2013)
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
Vlado Perkovic et al.
KIDNEY INTERNATIONAL (2013)
Cardiovascular effects of gliptins
Andre J. Scheen
NATURE REVIEWS CARDIOLOGY (2013)
Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways
Fei Fang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2013)
A Phase I First-in-Human Trial of Bardoxolone Methyl in Patients with Advanced Solid Tumors and Lymphomas
David S. Hong et al.
CLINICAL CANCER RESEARCH (2012)
Towards understanding the inherited susceptibility for nephropathy in diabetes
Merlin C. Thomas et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2012)
Benefits and Safety of Long-Term Fenofibrate Therapy in People With Type 2 Diabetes and Renal Impairment The FIELD Study
Ru-Dee Ting et al.
DIABETES CARE (2012)
Glomerular Hyperfiltration and Renal Disease Progression in Type 2 Diabetes
Piero Ruggenenti et al.
DIABETES CARE (2012)
Effects of Dapagliflozin, an SGLT2 Inhibitor, on HbA1c, Body Weight, and Hypoglycemia Risk in Patients With Type 2 Diabetes Inadequately Controlled on Pioglitazone Monotherapy
Julio Rosenstock et al.
DIABETES CARE (2012)
Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus
E. T. Rhodes et al.
DIABETIC MEDICINE (2012)
The PCSK9 decade
Gilles Lambert et al.
JOURNAL OF LIPID RESEARCH (2012)
Glomerular hyperfiltration and increased glomerular filtration surface are associated with renal function decline in normo- and microalbuminuric type 2 diabetes
Tatsumi Moriya et al.
KIDNEY INTERNATIONAL (2012)
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study
Ferdinando C. Sasso et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
A Clinical Trial to Maintain Glycemic Control in Youth with Type 2 Diabetes
Phil Zeitler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pentoxifylline for diabetic kidney disease
Dan Shan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2012)
Synthetic Oleanane Triterpenoids: Multifunctional Drugs with a Broad Range of Applications for Prevention and Treatment of Chronic Disease
Karen T. Liby et al.
PHARMACOLOGICAL REVIEWS (2012)
Preischemic targeting of HIF prolyl hydroxylation inhibits fibrosis associated with acute kidney injury
Pinelopi P. Kapitsinou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Mechanistic implications for LDL receptor degradation from the PCSK9/LDLR structure at neutral pH
Paola Lo Surdo et al.
EMBO REPORTS (2011)
Aliskiren improves insulin resistance and ameliorates diabetic vascular complications in db/db mice
Young Sun Kang et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure-function relation to therapeutic inhibition
G. Tibolla et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2011)
Adipokines in inflammation and metabolic disease
Noriyuki Ouchi et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Oxidative Stress and Diabetic Complications
Ferdinando Giacco et al.
CIRCULATION RESEARCH (2010)
The Influence of PCSK9 Polymorphisms on Serum Low-Density Lipoprotein Cholesterol and Risk of Atherosclerosis
Jean Davignon et al.
CURRENT ATHEROSCLEROSIS REPORTS (2010)
From Pre-Diabetes to Type 2 Diabetes in Obese Youth Pathophysiological characteristics along the spectrum of glucose dysregulation
Fida Bacha et al.
DIABETES CARE (2010)
Advanced glycation end-products and the kidney
Martin Busch et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Prevalence and Correlates of Elevated Blood Pressure in Youth with Diabetes Mellitus: The Search for Diabetes in Youth Study
Beatriz L. Rodriguez et al.
JOURNAL OF PEDIATRICS (2010)
Pathologic Classification of Diabetic Nephropathy
Thijs W. Cohen Tervaert et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
E. Maury et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus.
Lukasz Januszkiewicz
KARDIOLOGIA POLSKA (2010)
Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth Study
Lenna L. Liu et al.
PEDIATRIC DIABETES (2010)
Macrophages and Diabetic Nephropathy
Greg H. Tesch
SEMINARS IN NEPHROLOGY (2010)
Is exercise a therapeutic tool for improvement of cardiovascular risk factors in adolescents with type 1 diabetes mellitus? A randomised controlled trial
Mona A. Salem et al.
DIABETOLOGY & METABOLIC SYNDROME (2010)
Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure
Hyun Ju Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
Henry N. Ginsberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Impaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy
Leileata M. Russo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension-the impact of microalbuminuria: a 13-year follow-up study
Marit Dahl Solbu et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Rosiglitazone-associated fractures in type 2 diabetes - An analysis from a diabetes outcome progression trial (ADOPT)
Steven E. Kahn et al.
DIABETES CARE (2008)
Protein kinase C-β inhibition for diabetic kidney disease
Katherine R. Tuttle
DIABETES RESEARCH AND CLINICAL PRACTICE (2008)
What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?
S. C. Satchell et al.
DIABETOLOGIA (2008)
Proprotein convertase Subtilisin/Kexin type 9 (PCSK9): Hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration
Ahmed Zaid et al.
HEPATOLOGY (2008)
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study):: a multicentre, randomised, double-blind, controlled trial
Johannes F. E. Mann et al.
LANCET (2008)
A new era for Type 2 diabetes genetics
E. Zeggini
DIABETIC MEDICINE (2007)
Pirfenidone slows renal function decline in patients with focal segmental glomerulosclerosis
Monique E. Cho et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Update on microalbuminuria as a biomarker in renal and cardiovascular disease
Hiddo J. Lambers Heerspink et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2006)
Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria
George L. Bakris et al.
JOURNAL OF HYPERTENSION (2006)
The burden of diabetes mellitus among US youth: Prevalence estimates from the SEARCH for Diabetes in Youth Study
Angela D. Liese et al.
PEDIATRICS (2006)
Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: The SEARCH for Diabetes in Youth Study
Ann K. Kershnar et al.
JOURNAL OF PEDIATRICS (2006)
Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network
Angie L. Bookout et al.
CELL (2006)
Management of cardiovascular risk factors in advanced type 2 diabetic nephropathy: a comparative analysis in nephrology, diabetology and primary care settings
Roberto Minutolo et al.
JOURNAL OF HYPERTENSION (2006)
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy
FC Sasso et al.
DIABETES CARE (2006)
The pathobiology of diabetic complications - A unifying mechanism
M Brownlee
DIABETES (2005)
Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9
S Rashid et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Drug therapy: Thiazolidinediones
H Yki-Jarvinen
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome
YF Guan
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2004)
Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men
JP Gutzwiller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Contribution of polyol pathway to diabetes-induced oxidative stress
SSM Chung et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Peroxisome proliferator-activated receptor-α agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis
H Kim et al.
DIABETES (2003)
Regression of microalbuminuria in type 1 diabetes
BA Perkins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes
M Tanasescu et al.
CIRCULATION (2003)
Cardiovascular risk factors are differently associated with urinary albumin excretion in men and women
JC Verhave et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Low glomerular filtration rate in normoalbuminuric type 1 dihibetic patients - An indicator of more advanced glomerular lesions
ML Caramori et al.
DIABETES (2003)
Diabetic kidney disease: impact of puberty
PH Lane
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2002)
Cellular basis of diabetic nephropathy 1. Study design and renal structural-functional relationships in patients with long-standing type 1 diabetes
ML Caramori et al.
DIABETES (2002)
Pirfenidone treatment decreases transforming growth factor-β1 and matrix proteins and ameliorates fibrosis in chronic cyclosporine nephrotoxicity
FS Shihab et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
Type 2 diabetes in children: Clinical aspects and risk factors
S Arslanian
HORMONE RESEARCH (2002)
Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease
YF Guan et al.
KIDNEY INTERNATIONAL (2001)
Insulin resistance: definition and consequences
HE Lebovitz
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2001)
Hypoxia promotes fibrogenesis in human renal fibroblasts
JT Norman et al.
KIDNEY INTERNATIONAL (2000)
Role of the hexosamine biosynthetic pathway in diabetic nephropathy
ED Schleicher et al.
KIDNEY INTERNATIONAL (2000)
Share Paper
